MOBILE   |  REGISTER   |   LOGIN   |   HELP
HOME  |  ABOUT US  |  BLOGGERS  |  BLOGS  |  MESSAGES  |  VIDEO  |  QUIZZES  |  LIBRARY  |  WEBINARS
A Gated Community for Oncology Nurses and
Cancer Care Teams | More Info
Breast   |   Prostate   |   Lung   |   Hematology   |   Skin   |   Gastrointestinal   |   Genitourinary   |   Head / Neck   |   Brain   |   Gynecological   |   Sarcoma   |   Thyroid
Career  |  Exercise  |  Nutrition  |  Recipes  |  Survivorship  |  Symptom Management  |  Emergencies  |  Side Effects  |  Pediatrics  |  Complementary Therapies
Breast cancer
most recent users' messages
Blog Roll
Lori Smith

Lori Smith
FDA Warns of Breast Implant-Associated Anaplastic Large Cell Lymphoma
Lori Smith, BSN, MSN, CRNP
4/24/2017  0
The possibility of an association between breast implants and anaplastic large cell lymphoma-a rare type of non-Hodgkin lymphoma-was first recognized by the US Food and Drug ...

Marijke Vroomen Durning

Marijke Vroomen Durning
Breast Cancer Patients Need Better Access to Genetic Counseling
Marijke Vroomen Durning, RN
4/19/2017  1
Genetic counselors are an integral part of the medical team and can play a valuable role in supporting patients with illnesses such as cancer. Genetic counselors are trained not ...

Most recent post: GeneRN... Login to View
Carole McCue

Carole McCue
Direct Communication Improves Breast Cancer Screening Return Rate
Carole McCue, RN, MS, CNE
4/4/2017  0
The American Cancer Society (ACS) has recommended MRI screening as an adjunct to mammography for women at an increased risk of breast cancer. MRI utilizes magnetic fields to produce ...

Deborah A. Boyle

Deborah A. Boyle
Aromatase Inhibitor Endocrine Therapy and Quality of Survival
Deborah A. Boyle, RN, MSN, AOCNS, FAAN
3/28/2017  0
Aromatase inhibitor (AI) therapy has a proven track record to enhance disease-free survival and lower recurrence rates in women with hormone receptor-positive postmenopausal breast ...

Marijke Vroomen Durning

Marijke Vroomen Durning
Ribociclib Plus Letrozole Improves Survival in Metastatic Breast Cancer
Marijke Vroomen Durning, RN
3/20/2017  0
Ribociclib (Kisqali) has been approved by the US Food and Drug Administration (FDA) for use in combination therapy with an aromatase inhibitor for first-line treatment of hormone ...

Carole McCue

Carole McCue
Massage Therapy May Reduce Side Effects in Breast Cancer Patients
Carole McCue, RN, MS, CNE
1/23/2017  0
Chemotherapy can often result in fatigue, nausea, and sleep disruption. From a personal perspective, I experienced debilitating fatigue and actually questioned my oncologist as to ...

Deborah A. Boyle

Deborah A. Boyle
Adherence to Oral Cancer Drugs: The Key to Optimum Treatment Outcomes
Deborah A. Boyle, RN, MSN, AOCNS, FAAN
1/18/2017  0
I remember more than 2 decades ago having lunch with a radiation oncologist who specialized in breast cancer therapy. In this early era of prophylactic tamoxifen therapy she said to ...

Deborah A. Boyle

Deborah A. Boyle
Recent Lymphedema Evidence-Based Practice Findings for Oncology Providers
Deborah A. Boyle, RN, MSN, AOCNS, FAAN
1/11/2017  0
A major impediment to quality of survival in patients with breast cancer, lymphedema, and its prevention has been hampered by a lack of research to guide practice. Case in point is ...

Cathy Cole

Cathy Cole
Imaging Surveillance After a Breast Cancer Diagnosis
Cathy Cole, RNC, NP, MPH, CHES, CBPN-IC
11/18/2016  0
New findings presented at the 2016 Clinical Congress of the American College of Surgeons revealed that of the patients diagnosed with breast cancer, nearly one-third are not ...

Webinar Series
Tuesday, October 29, 2013 12:00 PM EDT
Archived

Presented by Ellen T. Matloff, MS, CGC , this webinar will highlight:

  • How to determine which patients require genetic counseling
  • How to help prepare your patients for the genetic counseling process
  • Testing options that are now available
  • How you can utilize this data in managing your patients and their family members

Participants will also be able to ask questions during a live question and answer period with speaker Ellen T. Matloff, MS, CGC .

Wednesday, August 28, 2013 12:00 PM EDT
Wednesday, June 26, 2013 12:00 PM EDT
Wednesday, April 10, 2013 12:00 PM EDT
Readerboards
Have a question or topic but don't want to write a blog? Post it on our readerboards and get feedback from the community!
estelary4 on Enhance your Business through Excellent Website Promotion
socorrofj1 on Enhance your Business through Excellent Website Promotion
socorrofj1 on Enhance your Business through Excellent Website Promotion
FDA Approves Onivyde for Advanced Pancreatic Cancer
Marijke Vroomen Durning, RN,
10/27/2015  3
On October 22, 2015, the US Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection, Merrimack Pharmaceuticals, Inc.), in combination with fluorouracil ...
Like Us on Facebook
on Twitter
TheONC Twitter Feed
TheONC.org